WeightWatchers 2015 Annual Report Download - page 29

Philippe J. Amouyal. Mr. Amouyal has been a director since November 2002. Mr. Amouyal is a Managing
Director of The Invus Group, LLC, a position he has held since 1999. Previously, Mr. Amouyal was a Vice
President and director of The Boston Consulting Group in Boston, MA. He holds an M.S. in Engineering and a
DEA in Management from Ecole Centrale de Paris and was a Research Fellow at the Center for Policy
Alternatives of the Massachusetts Institute of Technology. Mr. Amouyal is a director and member of the
Compensation Committee of Lexicon Pharmaceuticals, Inc. and Blue Buffalo Pet Products, Inc., as well as a
number of private companies of which Artal or Invus, L.P. are shareholders.
Cynthia Elkins. Ms. Elkins has been a director since March 2014. Since March 2011, Ms. Elkins has served
as the Vice President of IT Americas at Genentech, Inc., a member of the Roche Group, a leading biotechnology
company. She previously served as Genentech’s Senior Director of IT Enterprise Applications from December
2007 to February 2011. Prior to joining Genentech, Ms. Elkins was Vice President of Supplier Solutions and
Commerce Services at Ariba, Inc. and Vice President of Product Engineering at ATP Inc. Prior to that, she held
various IT positions at Aspect Telecommunications, VeriFone and Digital Equipment Corporation. Ms. Elkins
received a B.S. in Applied Mathematics from the University of California, Los Angeles and an M.B.A. from
Santa Clara University.
Jonas M. Fajgenbaum. Mr. Fajgenbaum has been a director since our acquisition by Artal Luxembourg S.A.
on September 29, 1999. Mr. Fajgenbaum is a Managing Director of The Invus Group, LLC, which he joined in
1996. Prior to joining The Invus Group, LLC, Mr. Fajgenbaum was a consultant for McKinsey & Company in
New York from 1994 to 1996. He graduated with a B.S. in Economics with a concentration in Finance from The
Wharton School of the University of Pennsylvania and a B.A. in Economics from the University of Pennsylvania.
Mr. Fajgenbaum is a director of a number of private companies of which Artal or Invus, L.P. are shareholders.
Denis F. Kelly. Mr. Kelly has been a director since May 2015. Mr. Kelly is a Partner, and served as a
Managing Partner, of Scura Paley Securities LLC, a private investment banking firm which he co-founded, since
2001. From 1993 to 2001, he was a Managing Director of Prudential Securities Incorporated. Previously, he
served as the President and Chief Executive Officer of Denbrook Capital Corporation, a merchant banking firm,
from 1991 to 1993. From 1980 to 1991, Mr. Kelly held various positions at Merrill Lynch, including Managing
Director of Mergers and Acquisitions and Managing Director of Merchant Banking. Mr. Kelly began his
investment banking career at Lehman Brothers in 1974. Mr. Kelly received a B.A. from Amherst College and an
M.B.A. from the Wharton School of Business of the University of Pennsylvania. Mr. Kelly is also a director of
MSC Industrial Direct Co., Inc., where he serves as a member of the Audit Committee and the chairman of the
Compensation Committee. Mr. Kelly previously served as a director of Kenneth Cole Productions, Inc., which is
no longer a public company.
Sacha Lainovic. Mr. Lainovic has been a director since our acquisition by Artal Luxembourg S.A. on
September 29, 1999. Since 2007, Mr. Lainovic has been Managing Partner of Invus Financial Advisors, LLC, a
New York-based investment firm, which he co-founded. From 1985 to 2006, Mr. Lainovic was Executive Vice
President of The Invus Group, LLC, which he co-founded. Prior to forming The Invus Group, LLC in 1985,
Mr. Lainovic was a manager and consultant for The Boston Consulting Group in Paris, France. He holds an
M.B.A. from Stanford Graduate School of Business and an M.S. in Engineering from Insa de Lyon in Lyon,
France.
Christopher J. Sobecki. Mr. Sobecki has been a director since our acquisition by Artal Luxembourg S.A. on
September 29, 1999. Mr. Sobecki is a Managing Director of The Invus Group, LLC, which he joined in 1989. He
received an M.B.A. from Harvard Business School. He also obtained a B.S. in Industrial Engineering from
Purdue University. Mr. Sobecki is a director of Lexicon Pharmaceuticals, Inc. and a number of private companies
of which Artal or Invus, L.P. are shareholders.
26